As we develop important new medicines to treat cancer, Millennium seeks to continuously demonstrate our ethical, clinical and scientific good intentions to the public.
We believe that patients, family members, health professionals and members of the public should have access to medically important information on Millennium clinical research.
Clinical Trial Enrollment
For information about enrolling patients in Millennium-sponsored clinical trials of investigational and marketed oncology drugs, please call 800-589-9005.
Millennium notifies the public of the start of all company-sponsored Phase I, II, III and IV clinical trials designed to test both the safety and efficacy of Millennium investigational and marketed oncology drugs on www.clinicaltrials.gov, a National Institutes of Health registry (a list) of ongoing clinical trials.
Clinical Trial Results
Millennium publishes results of completed, Phase II, Phase III and Phase IV clinical trials in a timely, objective, accurate and balanced manner – regardless of outcome.
When these trial results are published in a peer-reviewed journal, Millennium will post a citation (and, where possible, a link) to the journal article on www.clinicalstudyresults.org, a central, widely accessible clinical trials results database and the trial results on www.clinicaltrials.gov.
The publication of these results is consistent with Millennium's Core Values and applicable laws, regulations and guidelines regarding disclosure of clinical trial results including the Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results promulgated by the Pharmaceutical Research and Manufacturers of America (PhRMA).
To Learn More
To learn more about how clinical trials are conducted, search for clinical trials in your area, or learn whether you might qualify to participate in a clinical trial, visit www.clinicaltrials.gov.